Q32 Bio Inc [NASDAQ: QTTB] surged by $1.63 during the normal trading session on Monday and reaching a high of $6.3699 during the day while it closed the day at $3.82.
Q32 Bio Inc stock has also gained 91.00% of its value over the past 7 days. However, QTTB stock has inclined by 123.39% in the 3 months of the year. Over the past six months meanwhile, it has gained 108.74% and lost -84.77% year-on date.
The market cap for QTTB stock reached $47.01 million, with 12.30 million shares outstanding and 4.55 million shares in the current float. Compared to the average trading volume of 220.04K shares, QTTB reached a trading volume of 167431778 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Q32 Bio Inc [QTTB]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for QTTB shares is $15.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on QTTB stock is a recommendation set at 2.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Piper Sandler have made an estimate for Q32 Bio Inc shares, keeping their opinion on the stock as Neutral, with their previous recommendation back on February 11, 2025. While these analysts kept the previous recommendation, BMO Capital Markets raised their target price from $22 to $3. The new note on the price target was released on February 11, 2025, representing the official price target for Q32 Bio Inc stock. Previously, the target price had yet another drop from $95 to $16, while Wells Fargo kept a Equal Weight rating on QTTB stock. On December 11, 2024, analysts decreased their price target for QTTB shares from 90 to 22.
QTTB stock trade performance evaluation
Q32 Bio Inc [QTTB] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 91.00. With this latest performance, QTTB shares gained by 38.41% in over the last four-week period, additionally plugging by 108.74% over the last 6 months – not to mention a rise of 11.05% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for QTTB stock in for the last two-week period is set at 74.23, with the RSI for the last a single of trading hit 0.64, and the three-weeks RSI is set at 0.43 for Q32 Bio Inc [QTTB]. The present Moving Average for the last 50 days of trading for this stock 2.54, while it was recorded at 2.43 for the last single week of trading, and 2.05 for the last 200 days.
Q32 Bio Inc (QTTB) Capital Structure & Debt Analysis
Q32 Bio Inc (QTTB) Efficiency & Liquidity Metrics
Q32 Bio Inc (QTTB) Efficiency & Liquidity Metrics
From an operational efficiency perspective, Q32 Bio Inc. (QTTB) effectively leverages its workforce, generating an average of -$1002380.95 per employee. The company’s liquidity position is robust, with a Current Ratio of 4.57% and a Quick Ratio of 4.57%, indicating strong ability to cover short-term liabilities.
Earnings per share (EPS) analysis for Q32 Bio Inc [QTTB] stock
With the latest financial reports released by the company, Q32 Bio Inc posted -1.16/share EPS, while the average EPS was predicted by analysts to be reported at -1.53/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 0.37. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for QTTB. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Q32 Bio Inc go to 9.95%.
Q32 Bio Inc [QTTB]: Institutional Ownership
There are presently around $64.30%, or 68.75%% of QTTB stock, in the hands of institutional investors. The top three institutional holders of QTTB stocks are: ORBIMED ADVISORS LLC with ownership of 2.25 million shares, which is approximately 18.831%. ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC, holding 2.09 million shares of the stock with an approximate value of $$37.55 million in QTTB stocks shares; and ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC, currently with $$19.2 million in QTTB stock with ownership which is approximately 9.217%.
